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INTRODUCTION
Nonbacterial thrombotic endocarditis (NBTE) is an uncommon 
condition that describes aseptic lesions of the heart valves.1 His-
torically, NBTE has been synonymous with marantic endocarditis, 
Libman-Sacks endocarditis, and verrucous endocarditis. NBTE 
differs from culture-negative endocarditis, which describes infectious 
origins based on clinical history and symptomatology that have not 
been readily identified or difficult to culture.2 It is most commonly a 
postmortem finding (autopsy series 0.9 - 1.6%) and seen in advanced 
malignancy.2 
Based on autopsy reports, patients with an underlying malignancy 
are six times more likely to develop NBTE compared to the general 
population (1.25% vs. 0.2%).2 Solid tumor cancers are associated 
more commonly with NBTE, with mucin-secreting adenocarcino-
mas having the highest observed rates. The pathogenesis of NBTE is 
unclear, but endothelial injury plus hypercoagulability are thought to 
work synergistically. Interestingly, heart valve vegetations in NBTE 
have been discovered to be distinctly different from infectious veg-
etations. Due to the lack of an inflammatory reaction at the site of 
deposition, NBTE valvular vegetations are dislodged easily, explain-
ing their higher rates of embolization and end-organ infarction.2 This 
report presents a rare case of NBTE in a patient with newly diag-
nosed cancer. 
CASE REPORT
A 29-year-old female with a history of alcohol abuse and recurrent 
pancreatitis presented to her primary care physician complaining 
of severe dyspnea on exertion, fatigue, and pallor. The patient was 
referred to the emergency department for further evaluation after 
outpatient laboratory work revealed significant pancytopenia. She 
reported subjective fever, chills, sore throat, and productive cough. 
She denied any symptoms of bleeding at the time. The patient never 
used tobacco products and quit drinking alcohol several years prior 
to hospital admission. 
Family history was remarkable for a maternal grandfather with 
history of leukemia and Hodgkin’s lymphoma. Her vital signs on 
admission were remarkable for tachycardia. Physical examination 
was significant for skin pallor and dry mucosal. Complete Blood 
Count on presentation showed hemoglobin of 4 g/dl, platelets of 
56x109/L, and white blood cells of 14x109/L with 40% peripher-
al blasts, but the Disseminated Intravascular Coagulopathy panel 
was negative. Peripheral blood flow cytometry was concordant with 
a diagnosis of acute myelomonocytic leukemia (AMML). She was 
admitted to the hospital for transfusions and further workup.
A bone marrow biopsy confirmed the diagnosis of AMML with 
complex karyotype t (16;16) as well as negative NPM1 and CEBPA 
mutations. An initial echocardiogram revealed an ejection fraction of 
55% with no valvular abnormalities. She was started on broad spec-
trum antibiotics and blood cultures were collected on admission. 
Induction chemotherapy was initiated with cytarabine and daunoru-
bicin. Subsequent to chemotherapy treatment, her respiratory status 
rapidly deteriorated, eventually requiring intubation with worsening 
bilateral infiltrates on chest x-ray. Bronchoscopy done shortly after 
intubation was consistent with diffuse alveolar hemorrhage (DAH).
The patient developed neutropenic fever requiring her antibiotics 
to be expanded to vancomycin, meropenem, acyclovir, and voricon-
azole. Multiple sets of blood cultures were negative even though she 
continued to be persistently febrile with no source of infection.
 A week after being intubated, she suddenly developed signs of 
neurological damage including not withdrawing to pain and absent 
brainstem reflexes; a head CT could not be done to due respiratory 
instability. She quickly developed multi-organ failure and required 
continuous renal replacement therapy (CRRT). The patient also 
developed left leg ischemia caused by an arterial clot in the deep 
femoral artery. 
Family discussion led to comfort care. Autopsy revealed a massive 
non-hemorrhagic infarct involving left frontal, left parietal, and left 
occipital lobes of the brain resulting from an embolus originating 
from fibrin vegetation on the aortic valve (Figure 1A). There was 
pulmonary hemorrhage involving primarily the right and left lower 
lung lobes (Figure 1B). In addition, fibrin vegetations on the tricuspid 
valve were noted (Figure 1C). Multiple infarcts in the left and right 
kidney, as well as the spleen, were noted (Figure 1D). Fibrin thrombi 
within capillaries of both kidneys and lungs was compatible with dis-
seminated intravascular congestion.
Figure 1. Postmortem evidence of nonbacterial thrombotic endocarditis symp-
tomatology. A) Whole brain exam showing massive non-hemorrhagic infarct 
affecting multiple territories. B) Pulmonary hemorrhage. C) Fibrin vegetation 
on the aortic valve. D) Infarcts in bilateral kidneys.
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NBTE is a rare condition describing sterile thrombi deposition 
on heart valves in the absence of bacterial growth in blood cultures.1 
NBTE is clinically significant as it increases the risk of systemic 
embolic events including stroke (a rare event).3 This case is unusual in 
that the embolic phenomenon was fatal, as most cases are discovered 
incidentally post-mortem and are not well described in the literature. 
Microscopically, NBTE results from agglutinated platelets mixed 
with strands of fibrin, which is unusual in this case of severe throm-
bocytopenia.4 NBTE is most commonly associated with advanced 
malignancy (80% of cases), systemic lupus erythematosus, and 
antiphospholipid syndrome. The most common symptom of NBTE 
is embolic phenomena in up to 50% of patients rather than valvu-
lar dysfunction.5 In this case, NBTE led to significant morbidity and 
mortality from kidney failure requiring CRRT and massive stroke. 
Even though NBTE has a low incidence, when cultures yield negative 
results and significantly thrombogenic patients are not responsive 
to empirical antibiotic treatment, the possibility of NBTE should be 
considered.6 
CONCLUSION
This report described a rare case of NBTE in a young patient with 
a new diagnosis of Acute Myeloid Leukemia (AML). NBTE is a rare 
condition associated with high mortality and morbidity rates. It is 
uncommonly reported in patients with AML and is often a postmor-
tem diagnosis but can present with organ failure from infarction. 
Diagnosis of NBTE requires a high degree of clinical suspicion 
especially in patients with malignancy who have clinical features 
suggestive of endocarditis with a negative workup for an infectious 
etiology.
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